Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy

PURPOSE: Current standard of care for patients with breast cancer with a positive node on sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy is axillary dissection with irradiation of the regional nodes, but it is unknown whether axillary lymph node dissection (ALND) can be safely omit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, Diane C., Iarrobino, Nick A., Champ, Colin E., Soran, Atilla, Beriwal, Sushil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136630/
https://www.ncbi.nlm.nih.gov/pubmed/32280815
http://dx.doi.org/10.1016/j.adro.2019.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136630/
https://www.ncbi.nlm.nih.gov/pubmed/32280815
http://dx.doi.org/10.1016/j.adro.2019.09.006

Ejemplares similares